These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37039318)

  • 21. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
    La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
    Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions.
    Niccolai LM; Hansen CE
    Hum Vaccin Immunother; 2020 Dec; 16(12):3208-3212. PubMed ID: 32614695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.
    Hoe Nam L; Chiu CH; Heo JY; Ip M; Jung KS; Menzies R; Pearce R; Buchy P; Chen J; Nissen M; Oh KB
    Expert Rev Vaccines; 2021 Dec; 20(12):1603-1617. PubMed ID: 34734556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
    Stein-Zamir C; Israeli A
    Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults.
    Weston WM; Chandrashekar V; Friedland LR; Howe B
    Hum Vaccin; 2009 Dec; 5(12):858-66. PubMed ID: 19838080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal immunization: trends in South and Southeast Asian countries.
    Kamath GD; Kukreja S; Mukherjee P; Kolhapure S; Sathyanarayanan S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8372-8381. PubMed ID: 34517746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina.
    Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS
    Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.
    Havers FP; Cho BH; Walker JW; Hariri S
    Vaccine; 2020 Jan; 38(2):380-387. PubMed ID: 31676198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
    Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Booy R
    Vaccine; 2016 Nov; 34(48):5929-5937. PubMed ID: 27780630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.
    Elam-Evans LD; Yankey D; Jeyarajah J; Singleton JA; Curtis RC; MacNeil J; Hariri S; ;
    MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):625-33. PubMed ID: 25055186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™.
    Leonardi M; Latiolais T; Sarpong K; Simon M; Twiggs J; Lei P; Rinderknecht S; Blatter M; Bianco V; Baine Y; Friedland LR; Baccarini C; Miller JM
    Vaccine; 2015 Feb; 33(7):924-32. PubMed ID: 25305567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Fredua B; Singleton JA; Stokley S
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):718-723. PubMed ID: 31437143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.
    Stokley S; Cohn A; Jain N; McCauley MM
    Arch Pediatr Adolesc Med; 2011 Sep; 165(9):813-8. PubMed ID: 21893647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.